Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recapping the headwinds and tailwinds from Q3. Take a listen to this week's "Podnosis"
obesity drugs
Health Tech
Hims & Hers partners with Eli Lilly to sell Zepbound, Foundayo
Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.
Heather Landi
Nov 6, 2026 4:30pm
Fierce Pharma
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
May 28, 2026 11:20am
Him & Hers now offers all FDA-approved GLP-1s
Apr 23, 2026 10:43am
GoodRx launches Wegovy HD for $399 per month
Apr 15, 2026 1:38pm
Eli Lilly’s GLP-1 pill rolls out via US telehealth providers
Apr 9, 2026 11:45am
Novo Nordisk rolls out discounted subscription plan for Wegovy
Apr 2, 2026 4:30pm
